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Measurements and results:
In all neutropenie patients undergoing a tracheotomy, the characteristics and duration of both neutropenia and mechanical ventilation have been recorded. Stomal bleeding and infection, and infectious pneumonias and alveolar haemorrhage have been carefully reviewed. Platelets were transfused in 23 of the 26 patients at the time of the procedure; no local haemorrhage was observed. Neither stomal nor pulmonary infections secondary to tracheotomy were noted. No respiratory worsening was attributable to the tracheotomy. Nineteen patients (73%) died in ICU, without direct link between tracheotomy and death.
Introduction
Despite substantial improvements in the management of critically ill patients, the prognosis of neutropenic patients undergoing mechanical ventilation (MV) remains very poor, with a mortality rate of 80 to 100% [1] [2] [3] [4] . The main factors in this high mortality rate appear to be the duration of neutropenia, of MV during neutropenic period, and of stay in intensive care unit (ICU) [1, 21. The prognosis is also related to other factors such as the onset of nosocomial pneumonia and the indication for MV [4] [5] [6] .
It has been reported that tracheotomy reduces the duration of MV and ICU stay [9, 10] , and early tracheotomy (within 48 h of MV) could be associated with a lower incidence of nosocomial pneumonia, as suggested in multiple-trauma patients [5] . However, there are no data on the safety of this procedure in neutropenic (and usually thrombocytopenic) patients. We therefore assessed the safety of tracheotomy in neutropenic patients requiring mechanical ventilation, in terms of infectious and haemorrhagic complications.
Materials and methods
We reviewed the charts of all patients with chemotherapy-induced neutropenia referred to our ICU from 1987 to 1990. During this period, 125 neutropenic patients (WBC count < 1000/mm 3 and/or neutrophil count < 500/mm 3) were admitted, and 80 required MV. Of these 80 patients 26 were tracheotomized. Tracheotomy was per-formed either at the bedside or in the operating room, in surgical conditions and with general anesthesia. The tracheotomy protocol was standardized, as follows: small horizontal skin incision, separation of the strap muscles, separation and, when necessary, suture ligation of the thyroid isthmus. Hemostasis was obtained prior to incising the trachea, and the tracheostomy tube was inserted immediately to prevent air entry and emphysema. Skin closure, when necessary, was done with loose sutures.
The following characteristics were analyzed in each case: duration of neutropenia and MV, number of platelet units transfused immediately before the operative procedure, incidence of bleeding or local infection at the site of the tracheotomy, and indication for MV and tracheotomy. Lung infections were investigated endoscopically each time suspected by clinical or radiological findings. Bacterial pneumonia was defined by the isolation of 103 or more colony-forming units (CFU)/ml on a protected specimen brush. Fungi were considered to be responsible for pneumonia if isolated from the respiratory tract for Aspergillus, and if evidence of systemic fungal dissemination was obtained by organ biopsy or post-mortem examination for Candida. Viral pneumonia was diagnosed when a virus isolated from the respiratory tract had a cytopathic effect, e.g. the presence of Herpes simplex virus intranuclear inclusion bodies in bronchoalveolar lavage fluid. Alveolar haemorrhage was defined by the presence of more than 20% siderophages among cells recovered by bronchoalveolar lavage.
Results
Twenty-six neutropenic patients underwent tracheotomy ( Table 1 ). The indications for MV were a respiratory (n = 20) or a neurological failure (n = 4), a cardio-vascular arrest (n = 1) or a post-operative MV (n = 1); tracheotomies were performed 3.4 + 6.3 days after onset of MV (median: 1 day), because of long presumed durations of neutropenia and/or MV (early tracheotomies) or because unsuccessful weaning of MV (late procedures).
The mean duration of neutropenia was 24.2 + 23.6 days (mean_+SD), and the duration of MV was 14.5+11.2 days, 8.1 +7.1 days of which were during the neutropenic period. The WBC count on the day of tracheotomy was 264 +225/mm 3, and the platelet count was 43 _+ 32 • 103/ mm 3. Twenty-three patients received platelet transfusions before tracheotomy, in order to achieve a count of more than 50• 103/mm ~ at the time of the procedure.
No local bleeding was observed in the peri-operative period. Alveolar haemorrhage was diagnosed in two patients before tracheotomy, and did not worsen after the procedure. One patient who remained severely thrombocytopenic despite daily platelet transfusions (platelet count <20000/mm 3) developed interstitial pneumonia after 3 days after tracheotomy; bronchoalveolar lavage at day 6 revealed alveolar bleeding but no evidence of bleeding around the tracheotomy.
No stomal infections occurred. The five patients who developed documented infectious pneumonia (nonhaemolytic Streptococci, n = 2; Staphylococcus aureus, n = 1; Aspergillus fumigatus, n = l; Candida albicans, n = 1; Herpes simplex virus, n = l; one patient had two bacterias) did so before the tracheotomy procedure (Table   2 ). Radiographic pulmonary infiltrates extended after tracheotomy in two cases; the first patient (# 24) developed ARDS after cardiac arrest, requiring MV and early tracheotomy (day 1); in the other case (# 17), pulmonary infiltrates appeared on day 5 following tracheotomy and were associated with Streptococcus sanguis and Staphylococcus epidermidis bacteremia; both organisms were also recovered from the proximal aspirate, while plugged telescopic catheter specimens remained sterile. Since most of the patients were on antibiotics, a threshold lower than 103 CFU/ml on the protected specimen brush was also considered, without incidence on our results.
Two consecutive blood cultures yielded Bacteroides fragilis 3 days after tracheotomy in one patient, but the organism was not recovered from the respiratory tract.
Three consecutive blood cultures yielded an Acinetobacter spp. on the day of tracheotomy in another patient; the only other specimen from which this organism was recovered, despite a full bacteriologic work-up, was the feces.
The incidence of late tracheal complications such as granuloma and stenosis was not assessed systematically, but the 5 patients who left the hospital had no clinically symptomatic laryngo-tracheal complications several months later (two of them underwent a bronchoscopy for another reason, which did not reveal any laryngo-tracheal complication).
Nineteen patients (73~ died in the ICU from refractory hypoxia (n = 7), septic shock (n = 9), multiple organ failure (n = 2) or brain haemorrhage (n = 1). No direct link between tracheotomy and death was found.
Discussion
The mortality in neutropenic patients requiring MV is more than 80~ in most series [1 -3] . In Schuster's series, all patients who remained neutropenic for more than 5 days after the beginning of MV died [1] . Among the approaches used to reduce the mortality rate in this setting are the administration of growth factors to shorten neutropenia, and selective decontamination of the digestive tract to prevent nosocomial pneumonia, but the efficacy of both has been called into doubt [7, 8] .
Tracheotomy is usually recommended when prolonged ventilation is necessary [9, 10] ; moreover, tracheotomy has been claimed to reduce acquired pneumonia by improving airway suctioning and mouth care [9] . On the other hand, tracheotomy may cause haemorrhaging and stomal infection [11, 12] .
Since 1987 we have tracheotomized neutropenic patients when local conditions permit, if it is likely to be beneficial given three main criterias of decision: the presumed durations of neutropenia, of MV during neutropenic period, or the inability to obtain the weaning of MV or efficient airway suctioning (particularly because of persistent tracheal haemorrhage in thrombocytopenic patients). Our results suggest that tracheotomy is safe when adequate platelet transfusion are given prior to the procedure, including patients with refractory thrombocytopenia (because of anti-platelets antibodies). No local bleeding or infection was observed in this series, and deaths never appeared to be related to the procedure. Moreover, there were no cases of acquired pneumonia directly due to the tracheotomy, in contrast to other reports [12] . Only one patient had a positive blood culture Table 1 Characteristics of the 26 patients undergoing tracheotomy during neutropenia (ALL Acute lymphocytic leukemia, NSTC non seminomatous testis cancer, (+) yes, (-) no, NHL (Acinetobacter spp.) within 2 days after tracheotomy, and the only other specimen positive for this organism was the feces. Finally, there were no late symptomatic tracheal stenoses, although this lack of late complications must be confirmed in a prospective study.
In conclusion, tracheotomy appears to be safe in neutropenic patients requiring MV. The usefulness of early tracheotomy, which has been suggested to reduce the incidence of acquired pneumonia in multiple-trauma patients, warrants a randomized trial in this setting. 
